Department of Psychiatry, Columbia University, New York, New York.
New York State Psychiatric Institute, New York, New York.
Autism Res. 2020 Feb;13(2):187-198. doi: 10.1002/aur.2232. Epub 2019 Nov 14.
16p11.2 copy-number variation (CNV) is implicated in neurodevelopmental disorders, with the duplication and deletion associated with autism spectrum disorder (ASD) and the duplication associated with schizophrenia (SCZ). The 16p11.2 CNV may therefore provide insight into the relationship between ASD and SCZ, distinct disorders that co-occur at an elevated rate, and are difficult to distinguish from each other and from common co-occurring diagnoses such as obsessive compulsive disorder (OCD), itself a potential risk factor for SCZ. As psychotic symptoms are core to SCZ but distinct from ASD, we sought to examine their predictors in a population (n = 546) of 16p11.2 CNV carriers and their noncarrier siblings recruited by the Simons Variation in Individuals Project. We hypothesized that psychotic symptoms would be most common in duplication carriers followed by deletion carriers and noncarriers, that an ASD diagnosis would predict psychotic symptoms among CNV carriers, and that OCD symptoms would predict psychotic symptoms among all participants. Using data collected across multiple measures, we identified 19 participants with psychotic symptoms. Logistic regression models adjusting for biological sex, age, and IQ found that 16p11.2 duplication and ASD diagnosis predicted psychotic symptom presence. Our findings suggest that the association between 16p11.2 duplication and psychotic symptoms is independent of ASD diagnosis and that ASD diagnosis and psychotic symptoms may be associated in 16p11.2 CNV carriers. Autism Res 2020, 13: 187-198. © 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: Either deletion or duplication at chromosome 16p11.2 raises the risk of autism spectrum disorder, and duplication, but not deletion, has been reported in schizophrenia (SCZ). In a sample of 16p11.2 deletion and duplication carriers, we found that having the duplication or having an autism diagnosis may increase the risk of psychosis, a key feature of SCZ.
16p11.2 拷贝数变异 (CNV) 与神经发育障碍有关,其重复和缺失与自闭症谱系障碍 (ASD) 相关,而重复与精神分裂症 (SCZ) 相关。因此,16p11.2 CNV 可能提供了一个深入了解 ASD 和 SCZ 之间关系的视角,这两种疾病的发病率较高,且难以区分,与常见的共病诊断(如强迫症,强迫症本身是 SCZ 的潜在危险因素)也难以区分。由于精神病症状是 SCZ 的核心特征,与 ASD 不同,我们试图在由西蒙斯个体变异项目招募的 16p11.2 CNV 携带者及其非携带者兄弟姐妹(共 546 人)中研究这些症状的预测因素。我们假设,在重复携带者中精神病症状最常见,其次是缺失携带者和非携带者,ASD 诊断可以预测 CNV 携带者的精神病症状,强迫症症状可以预测所有参与者的精神病症状。使用跨多种测量方法收集的数据,我们确定了 19 名有精神病症状的参与者。调整生物学性别、年龄和智商的逻辑回归模型发现,16p11.2 重复和 ASD 诊断预测了精神病症状的存在。我们的研究结果表明,16p11.2 重复与精神病症状之间的关联独立于 ASD 诊断,而 ASD 诊断和精神病症状可能与 16p11.2 CNV 携带者有关。自闭症研究 2020, 13: 187-198. © 2019 国际自闭症研究协会,威利期刊,公司。
备注:英文原文中有一些人名和项目名,以及一些不影响理解的括号注释,为了中文表述的流畅性,在翻译时被删去了。